Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations

Dong Chen, Guang Liu, Michael R. Lewis, Xia Li, Matthew Ulrickson, Rajneesh Nath, Weina Chen

Research output: Contribution to journalArticlepeer-review

Abstract

We report a case of myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement (MLNZMYM2::FGFR1) exhibiting a complex disease evolution. This neoplasm initially presented as T-lymphoblastic lymphoma (T-LBL) in lymph node and myeloproliferative neoplasm (MPN) with eosinophilia in bone marrow, then transitioned to systemic mastocytosis (SM) likely accompanied by additional JAK3 and other mutations and finally transformed to acute myeloid leukemia (AML) accompanied by additional/secondary genetic abnormality (gain of chromosome 21, der(13)t(8;13), and RUNX1 mutation). To our knowledge, this is the first case of MLNZMYM2::FGFR1 with a complex trilineage/phenotypic [T-cell (T-LBL), mast cell (SM), and myeloid (MPN and AML)] lineage evolution.

Original languageEnglish (US)
Article number100370
JournalLeukemia Research Reports
Volume19
DOIs
StatePublished - Jan 2023

Keywords

  • Acute myeloid leukemia
  • Myeloid/lymphoid neoplasm with FGFR1 rearrangement (MLN)
  • Systemic mastocytosis
  • T-lymphoblastic lymphoma
  • ZMYM2::FGFR1

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations'. Together they form a unique fingerprint.

Cite this